Federal Service for Intellectual Property (Rospatent) has summed up the results of the year 2021. According to RIA Novosti, the head of Rospatent Grigory...
Russia’s Gamaleya National Research Center for Epidemiology and Microbiology is launching trials of its new anti-COVID medicine based on monoclonal antibodies, the center’s chief...
The World Health Organization (WHO) reccommended two new drugs to treat patients with COVID-19, one for patients with critical disease, and another deemed effective...
Finance Minister Hong Nam-ki said Thursday the government plans to spend 6.3 trillion won (US$5.3 billion) to support corporate facility investment in vaccine development...